missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ GRL 0617

Click to view available options
Quantity:
25 mg
Unit Size:
25mg
Description
GRL 0617 is a coronavirus papain-like protease (Plpro) inhibitor (IC50 values are 0.6 and 0.8 μM for SARS-COV and SARS-CoV-2 PLpro, respectively). Inhibits deubiquitination activity of SARS-CoV PLpro. Displays no inhibition of human deubiquitinating enzymes. Improves cell viability following SARS-CoV infection. Inhibits SARS-CoV-2 viral replication and induces antiviral immune signaling pathways following SARS-CoV-2 infection in CaCo-2 cells.

Specifications
Specifications
Chemical Name or Material | 5-Amino-2-methyl-N-[(1 R)-1-(1-naphthalenyl)ethyl]benzamide |
CAS | 1093070-16-6 |
Quantity | 25 mg |
Target | Papain-like Protease Inhibitors |
Molecular Formula | C20H20N2O |
Purity | 0.98 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction